Evidence map›Paper›PMID 15815682›Full record

ReviewGene therapy2005

Gene therapy progress and prospects: targeted gene repair.

H Parekh-Olmedo, L Ferrara, E Brachman, E B Kmiec

Abstract readReview
PubMed Publisher
In one paragraph

Review in Gene therapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. On the Origins of Homology Directed Repair in Mammalian Cells.International journal of molecular sciences · 2021
    Article
  5. CRISPR-DirectedThe CRISPR journal · 2018
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Gene therapy in periodontics.Journal of Indian Society of Periodontology · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Gene therapy for the inner ear: challenges and promises.Advances in oto-rhino-laryngology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

H Parekh-OlmedoDepartment of Biological Sciences, Delaware Biotechnology Institute, University of Delaware, Newark, DE 19716, USA.
L Ferrara
E Brachman
E B Kmiec

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity to correct a mutant gene within the context of the chromosome holds great promise as a therapy for inherited disorders but fulfilling this promise has proven to be challenging. However, steady progress is being made and the development of gene repair as a viable and robust approach is underway. Here, we present some of the recent advances that are helping to shape our thinking about the feasibility and the limitations of this technique. For the most part, these advances center on understanding the regulation of the reaction and validating its application in animal models.

Indexed as

DNA RepairDNA, Single-StrandedGene Expression RegulationGene TargetingGenetic Diseases, InbornGenetic TherapyHumansPoint MutationDNA, Single-Stranded

Identifiers

PMID15815682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.